Medical and Pharmaceutical bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test It will be issued within 3 months provided that there are no opposition filings made by third parties Rowan DunneJanuary 22, 2025
Medical and Pharmaceutical University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research The Canadian Cancer Society reports that healthcare professionals diagnose over 100 types of cancer-related diseases each year Joseph MortonJanuary 21, 2025
Medical and Pharmaceutical Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug 'Limertinib' targets non-small cell lung cancer with a particular mutation that is prevalent in Asian patients Rowan DunneJanuary 17, 2025
Medical and Pharmaceutical South Korean researchers come up with novel treatment option for lung cancer Non-small cell lung cancer constitutes 85 per cent of all lung cancer cases Joseph MortonJanuary 16, 2025
Uranium Radon Action Month highlights need for higher lung cancer screening rates Multiple states recognize January as a month to promote awareness about the dangers of radon gas Rowan DunneJanuary 14, 2025
Medical and Pharmaceutical ‘ORACLE’ lung cancer test helps predict survival with superior precision British researchers just published an extensive study on the tissue biopsy in Nature Cancer Rowan DunneJanuary 13, 2025
Medical and Pharmaceutical Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40% It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday Rowan DunneJanuary 9, 2025
Medical and Pharmaceutical Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment Rowan DunneJanuary 7, 2025
AI and Autonomy Predictive Oncology shares rise 71% as takeover by Renovaro is announced Both companies are focused on AI-powered drug discovery Rowan DunneJanuary 6, 2025
Medical and Pharmaceutical Roche secures rights to Chinese biotech company’s small cell lung cancer drug Innovent Biologics will receive up to US$1 billion in milestone payments and royalties Rowan DunneJanuary 3, 2025